Ryvu Therapeutics press releases
The latest press releases from Ryvu Therapeutics (WSE: RVU), gathered from its own newsroom and from the newswires that carry it. PPN World follows 1,400+ press release feeds and adds each Ryvu Therapeutics release within minutes of publication.
- Listing
- WSE: RVU
- Latest release
- Nov 4, 2026
- On this page
- 2 newest releases
Latest Ryvu Therapeutics press releases
- 美纳里尼集团和 Ryvu Therapeutics 在 2026 年 ASH 年会上公布了针对严重预处理的复发/难治性侵袭性 B 细胞非霍奇金淋巴瘤的 dapolsertib（MEN1703、SEL24） 二期 JASPIS-01 研究的首批临床数据
dapolsertib 单一疗法的首批临床数据： 针对已用尽现有标准治疗选择的复发/难治性 (r/r) 侵袭性 B 细胞非霍奇金淋巴瘤 (B-NHL) 患者的同类首创口服 PIM/FLT3 激酶抑制剂 dapolsertib (MEN1703) 的 II 期 JASPIS-01 研究的初步结果。 在经过大量预处理的人群中观察到的临床活性： 在先前接受过四种治疗的中位数的人群中观察到临床活性 ；53…
- Menarini Group and Ryvu Therapeutics Announce First Clinical Data from the Phase II JASPIS-01 Study of dapolsertib (MEN1703, SEL24) in Heavily Pretreated Relapsed/Refractory Aggressive B-cell non-Hodgkin Lymphoma at the 2026 ASH Annual Meeting
FLORENCE, Italy and KRAKOW, Poland, Nov. 04, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (…
PPN World is independent and not affiliated with Ryvu Therapeutics. Headlines and short excerpts only; each release links to its source.
Questions
Where can I find Ryvu Therapeutics press releases?+
How do I get an alert when Ryvu Therapeutics publishes a press release?+
Is this Ryvu Therapeutics's official newsroom?+
Know the minute Ryvu Therapeutics publishes
Watch Ryvu Therapeutics, its competitors and its sector in one live feed, with email alerts — on the free plan.